치주질환 치료 시장 예측 : 제품, 질환 유형, 치료 유형, 약제, 투여 경로, 유통 채널, 최종 사용자, 지역별 세계 예측(-2030)

According to Stratistics MRC, the Global Periodontal Disease Treatment Market is accounted for $908.61 million in 2024 and is expected to reach $1717.94 million by 2030 growing at a CAGR of 11.2% during the forecast period. Periodontal disease treatment focuses on managing and reversing the damage caused by gum infections that affect the tissues surrounding and supporting the teeth. In order to lower inflammation and bacteria, the treatment usually starts with a professional cleaning called scaling and root planing, which involves removing plaque and tartar from the teeth and under the gum line. Moreover, antibiotics or antimicrobial therapies may also be recommended to prevent infection and encourage recovery.

According to the National Institute of Dental and Craniofacial Research (NIDCR), periodontal disease is a leading cause of tooth loss in adults, affecting nearly 70% of adults aged 65 years and older.

Market Dynamics:

Driver:

Increasing periodontal disease prevalence

One of the key factors propelling the market for periodontal disease treatments is the rising incidence of these conditions. According to the Centers for Disease Control and Prevention (CDC), 47.2% of American adults over 30 suffer from some kind of periodontal disease. The number of people with this condition rises with population age, especially among older adults. Additionally, people with certain risk factors-such as diabetes, smoking, and poor oral hygiene habits-are more likely to suffer from periodontal diseases. Across all age groups, there is a persistent need for preventative and therapeutic treatments for periodontal disease due to the higher prevalence of these factors in the general population.

Restraint:

High expenses of treatment

One of the major restraints for the periodontal disease treatment market is the high cost of advanced treatments, especially in regions where dental insurance coverage is limited. The high cost of procedures like bone grafting, regenerative treatments, and advanced laser therapies may discourage many people from getting treatment when they need it. The expense is further increased by the fact that many treatments for periodontal disease necessitate several dental appointments. Due to lower healthcare spending and a lack of widespread dental insurance, these treatments are even more difficult to afford in developing nations.

Opportunity:

Integration with the management of systemic health

People are becoming more aware of the link between dental health and general health, especially when it comes to systemic diseases like diabetes, heart disease, and respiratory disorders. The opportunity to incorporate periodontal care with more comprehensive healthcare management is increasing as more research relates periodontal disease to these health problems. This offers dental practitioners and physicians the chance to work together to provide patients with more comprehensive care. Additionally, some healthcare systems may include treatment for periodontal disease in their overall disease management plans, opening up new opportunities for dental professionals to collaborate with other medical professionals.

Threat:

Rivalry from over-the-counter items

Over-the-counter (OTC) products that claim to manage or lessen the symptoms of gum disease pose a serious threat to the market for periodontal disease treatments. These goods include fluoridated toothpaste, antimicrobial mouthwashes, and a variety of household appliances like electric toothbrushes and flossing implements. Moreover, these over-the-counter (OTC) products are widely available, reasonably priced, and frequently heavily marketed to consumers, even though they might not be as effective as professional treatments. Due to convenience, affordability, or a lack of knowledge about the seriousness of their condition, many patients may decide to use these over-the-counter substitutes rather than seek professional periodontal care.

Covid-19 Impact:

The market for periodontal disease treatments was significantly impacted by the COVID-19 pandemic, mainly because of the prohibitions on in-person medical visits and the suspension of non-essential dental procedures during lockdowns. Due to the forced closure of many dental offices or the restriction of services to emergency care, periodontal treatments were either postponed or avoided. The demand for professional periodontal care decreased as a result of some patients delaying or canceling regular dental appointments out of fear of catching the virus in medical facilities. Additionally, patients were less willing to spend money on non-urgent dental procedures as a result of the pandemic's economic uncertainty, which decreased their disposable income.

The Chronic Periodontal Disease segment is expected to be the largest during the forecast period

The Chronic Periodontal Disease segment is expected to account for the largest market share during the forecast period. In order to prevent tooth loss and restore oral health, chronic periodontal disease is a common condition among adults and is usually caused by factors like poor oral hygiene, smoking, diabetes, and genetic predisposition. Because of its widespread occurrence, especially in aging populations, chronic periodontal disease accounts for a significant portion of dental treatments. Furthermore, chronic periodontal disease is characterized by long-term inflammation and infection of the gums, which over time causes the gradual destruction of the supporting structures of the teeth, including the bone.

The Dental Clinics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Dental Clinics segment is predicted to witness the highest growth rate. The growing number of specialized periodontal care clinics, increased patient awareness of oral health, and the growing desire for more individualized, easily accessible dental treatments are all contributing to this segment's notable growth. From sophisticated surgical procedures to non-surgical methods like scaling and root planing, dental clinics provide a broad range of periodontal treatments. This market is expanding due to the rising demand for aesthetic dentistry as well as better accessibility and affordability of services. Moreover, dental clinics are becoming the main location for managing periodontal disease as more patients look for affordable and practical treatment options, which are fueling their explosive market expansion.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The high incidence of periodontal diseases, sophisticated healthcare facilities, and strong awareness of oral health are the main factors contributing to the region's dominance. Advanced periodontal treatments, such as surgical and regenerative procedures, are widely accessible in the United States, which boasts a well-established dental care system. The area's dominant position in the market is also a result of high healthcare spending, a sizable aging population, and robust dental insurance coverage. Furthermore, North America's market share in the treatment of periodontal disease is further reinforced by the existence of significant players in dental technologies and products as well as continuous research and development.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. The increasing incidence of periodontal diseases brought on by urbanization, dietary modifications, and growing awareness of oral health are some of the factors contributing to this growth. Significant advancements are being made in the region's healthcare system, especially in nations like China, India, and Japan, which are increasing access to dental care. A rapidly aging population and rising disposable incomes are also driving up demand for periodontal treatments. Moreover, the adoption of advanced treatments for periodontal disease is expected to grow significantly in the Asia-Pacific region as dental clinics and healthcare facilities become more accessible and widespread.

Key players in the market

Some of the key players in Periodontal Disease Treatment market include 3M Company, Keystone Dental Inc., DentalEZ, Inc., Envista Holdings Corporation, Bego GmbH & Co. KG, Millennium Dental Technologies, Inc., Straumann Group, Geistlich Pharma AG, Brasseler USA, Nova Instruments, A-Dec Inc., Parkell, Inc., Bausch Health Companies Inc., Yoshida Dental MFG. Co., Ltd. and PreXion, Inc.

Key Developments:

In November 2024, Geistlich Pharma AG announced an exclusive national distribution partnership agreement with StimLabs of Roswell, GA. StimLabs will assume all commercial activities for Geistlich's Advanced Wound Matrix effective immediately, offering a leading and clinically proven solution for acute and chronic wounds.

In November 2024, Nova announced that it has entered into a definitive agreement to acquire Sentronics Metrology GmbH, a privately held company headquartered in Mannheim Germany, in an all-cash transaction valued at approximately $60 million. The acquisition is subject to customary closing and regulatory conditions and approvals and is expected to close within the first quarter of 2025.

In August 2023, Keystone Dental Holdings, Inc. and Check-Cap Ltd. announced that they have entered into a definitive Business Combination Agreement under which the stockholders of Keystone Dental will become the majority holders of the combined company.

Products Covered:

• Equipment
• Consumables

Disease Types Covered:

• Gingivitis
• Chronic Periodontal Disease
• Aggressive Periodontal Disease
• Other Disease Types

Treatment Types Covered:

• Non-surgical Treatments
• Surgical Treatments

Drugs Covered:

• Systematic Antibiotics
• Local Antibiotics

Route of Administrations Covered:

• Oral
• Injectable

Distribution Channels Covered:

• Hospital Pharmacies
• Retail Pharmacies
• Other Distribution Channels

End Users Covered:

• Hospitals
• Dental Clinic
• Dental Academics and Research Institutes
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Periodontal Disease Treatment Market, By Product

• 5.1 Introduction
• 5.2 Equipment
  • 5.2.1 Lasers
  • 5.2.2 Ultrasonic Scalers
  • 5.2.3 Surgical Instruments
• 5.3 Consumables
  • 5.3.1 Dental Implants
  • 5.3.2 Bone Grafts
  • 5.3.3 Membranes

6 Global Periodontal Disease Treatment Market, By Disease Type

• 6.1 Introduction
• 6.2 Gingivitis
• 6.3 Chronic Periodontal Disease
• 6.4 Aggressive Periodontal Disease
• 6.5 Other Disease Types

7 Global Periodontal Disease Treatment Market, By Treatment Type

• 7.1 Introduction
• 7.2 Non-surgical Treatments
  • 7.2.1 Scaling and Root Planing
  • 7.2.2 Antibiotic Therapy
• 7.3 Surgical Treatments
  • 7.3.1 Flap Surgery
  • 7.3.2 Bone Grafting
  • 7.3.3 Guided Tissue Regeneration

8 Global Periodontal Disease Treatment Market, By Drug

• 8.1 Introduction
• 8.2 Systematic Antibiotics
• 8.3 Local Antibiotics

9 Global Periodontal Disease Treatment Market, By Route of Administration

• 9.1 Introduction
• 9.2 Oral
• 9.3 Injectable

10 Global Periodontal Disease Treatment Market, By Distribution Channel

• 10.1 Introduction
• 10.2 Hospital Pharmacies
• 10.3 Retail Pharmacies
• 10.4 Other Distribution Channels

11 Global Periodontal Disease Treatment Market, By End User

• 11.1 Introduction
• 11.2 Hospitals
• 11.3 Dental Clinic
• 11.4 Dental Academics and Research Institutes
• 11.5 Other End Users

12 Global Periodontal Disease Treatment Market, By Geography

• 12.1 Introduction
• 12.2 North America
  • 12.2.1 US
  • 12.2.2 Canada
  • 12.2.3 Mexico
• 12.3 Europe
  • 12.3.1 Germany
  • 12.3.2 UK
  • 12.3.3 Italy
  • 12.3.4 France
  • 12.3.5 Spain
  • 12.3.6 Rest of Europe
• 12.4 Asia Pacific
  • 12.4.1 Japan
  • 12.4.2 China
  • 12.4.3 India
  • 12.4.4 Australia
  • 12.4.5 New Zealand
  • 12.4.6 South Korea
  • 12.4.7 Rest of Asia Pacific
• 12.5 South America
  • 12.5.1 Argentina
  • 12.5.2 Brazil
  • 12.5.3 Chile
  • 12.5.4 Rest of South America
• 12.6 Middle East & Africa
  • 12.6.1 Saudi Arabia
  • 12.6.2 UAE
  • 12.6.3 Qatar
  • 12.6.4 South Africa
  • 12.6.5 Rest of Middle East & Africa

13 Key Developments

• 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 13.2 Acquisitions & Mergers
• 13.3 New Product Launch
• 13.4 Expansions
• 13.5 Other Key Strategies

14 Company Profiling

• 14.1 3M Company
• 14.2 Keystone Dental Inc.
• 14.3 DentalEZ, Inc.
• 14.4 Envista Holdings Corporation
• 14.5 Bego GmbH & Co. KG
• 14.6 Millennium Dental Technologies, Inc.
• 14.7 Straumann Group
• 14.8 Geistlich Pharma AG
• 14.9 Brasseler USA
• 14.10 Nova Instruments
• 14.11 A-Dec Inc.
• 14.12 Parkell, Inc.
• 14.13 Bausch Health Companies Inc.
• 14.14 Yoshida Dental MFG. Co., Ltd.
• 14.15 PreXion, Inc.